Designing a non-virulent HIV-1 strain: Potential implications for vaccine and experimental research

Journal of Research in Medical Sciences

Volumn 12, Issue 5, 2007, Pages 227-234

  Rezaei, Abbas ^a   Zabihollahi, Rezvan ^a   Salehi, Mansoor ^a   Moghim, Sharareh ^a   Tamizifar, Hasan ^a   Yazdanpanahi, Nasrin ^a   Amini, Gilda ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

HIV 1; Mutant; mzNL4 3; Non infectious; Safe research; Vaccine

Indexed keywords

GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTEGRASE; MESSENGER RNA; POL PROTEIN; RNA DIRECTED DNA POLYMERASE; VIRUS ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; DELETION MUTANT; GENE AMPLIFICATION; GENE DELETION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMAL CELL; NONHUMAN; POLYMERASE CHAIN REACTION; RNA TRANSLATION; STRAIN DIFFERENCE; TARGET CELL; VACCINATION; VIRION; VIRUS GENOME; VIRUS MUTANT; VIRUS REPLICATION; VIRUS VIRULENCE;

EID: 35948952843     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Failures of Host Defense Mechanisms. In Immunobiology. Edited by Janeway C, Travers P, Walport M, Shlomchik M. London: Garland Science; 2001:450-465.
2. Lodmell JS, Ehresmann C, Ehresmann B, Marquet R: Structure and dimerization of HIV-1 kissing loop aptamers. J Mol Biol 2001, 311: 475-490.
3. Sakuragi J, Iwamoto A, Shioda T: Dissociation of genome dimerization from packaging functions and virion maturation of human immunodeficiency virus type 1. J Virol 2002, 76: 959-967.
4. Sakuragi J, Shioda T, Panganiban AT: Duplication of the primary encapsidation and dimer linkage region of human immunodeficiency virus type 1 RNA results in the appearance of monomeric RNA in virions. J Virol 2001, 75: 2557-2565.
5. Takahashi KI, Baba S, Chattopadhyay P, Koyanagi Y, Yamamoto N, Takaku H et al.: Structural requirement for the two-step dimerization of human immunodeficiency virus type 1 genome. RNA 2000, 6: 96-102.
6. Coffin J, Hughes S, Varmus H: Reverse Transcriptase and the Generation of Retroviral DNA. In Retroviruses. Edited by Harold E. New York: Cold Spring Harbor Laboratory Press; 1997.
7. Dietrich L, Ehrlich LS, LaGrassa TJ, Ebbets-Reed D, Carter C: Structural consequences of cyclophilin A binding on maturational refolding in human immunodeficiency virus type 1 capsid protein. J Virol 2001, 75: 4721-4733.
8. Saphire AC, Bobardt MD, Gallay PA: Cyclophilin a plays distinct roles in human immunodeficiency virus type 1 entry and postentry events, as revealed by spinoculation. J Virol 2002, 76: 4671-4677.
9. Forshey BM, Shi J, Aiken C: Structural requirements for recognition of the human immunodeficiency virus type 1 core during host restriction in owl monkey cells. J Virol 2005, 79: 869-875.
10. Cook PR: A model for reverse transcription by a dimeric enzyme. J Gen Virol 1993, 74 (Pt 4): 691-697.
11. Katzinan M, Sudol M, Pufnock JS, Zeto S, Skinner LM: Mapping target site selection for the non-specific nuclease activities of retroviral integrase. Virus Res 2000, 66: 87-100.
12. Rinke CS, Boyer PL, Sullivan MD, Hughes SH, Linial ML: Mutation of the catalytic domain of the foamy virus reverse transcriptase leads to loss of processivity and infectivity. J Virol 2002, 76: 7560-7570.
13. Cristofaro JV, Rausch JW, Le Grice SF, DeStefano JJ: Mutations in the ribonuclease H active site of HIV-RT reveal a role for this site in stabilizing enzyme-primer-template binding. Biochemistry 2002, 41: 10968-10975.
14. McBurney SP, Young KR, Nwaigwe CI, Soloff AC, Cole KS, Ross TM: Lentivirus-like particles without reverse transcriptase elicit efficient immune responses. Curr HIV Res 2006, 4: 475-484.
15. Nakamura T, Masuda T, Goto T, Sano K, Nakai M, Harada S: Lack of infectivity of HIV-1 integrase zinc finger-like domain mutant with morphologically normal maturation. Biochem Biophys Res Commun 1997, 239: 715-722.
16. Rose JR, Babe LM, Craik CS: Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity. J Virol 1995, 69: 2751-2758.
17. Gabus C, Derrington E, Leblanc P, Chnaiderman J, Dormont D, Swietnicki W et al.: The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1. J Biol Chem 2001, 276: 19301-19309.
18. Sakuragi J, Ueda S, Iwamoto A, Shioda T: Possible role of dimerization in human immunodeficiency virus type 1 genome RNA packaging. J Virol 2003, 77: 4060-4069.
19. Mark-Danieli M, Laham N, Kenan-Eichler M, Castiel A, Melamed D, Landau M et al.: Single point mutations in the zinc finger motifs of the human immunodeficiency virus type 1 nucleocapsid alter RNA binding specificities of the gag protein and enhance packaging and infectivity. J Virol 2005, 79: 7756-7767.
20. Kumar M, Keller B, Makalou N, Sutton RE: Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther 2001, 12: 1893-1905.
21. Adachi A, Gendelman BE, Koenig S, Folks T, Willey F, Rabson A et al.: Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986, 59: 284-291.
22. Zhu K, Dobard C, Chow SA: Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase. J Virol 2004, 78: 5045-5055.
23. Diallo K, Marchand B, Wei X, Cellai L, Gotte M, Wainberg MA: Diminished RNA primer usage associated with the L74V and M184V mutations in the reverse transcriptase of human immunodeficiency virus type 1 provides a possible mechanism for diminished viral replication capacity. J Virol 2003, 77: 8621-8632.
24. Wei X, Liang C, Gotte M, Wainberg MA: The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses. AIDS 2002, 16: 2391-2398.
25. Wei X, Liang C, Gotte M, Wainberg MA: Negative effect of the M184V mutation in HIV-1 reverse transcriptase on initiation of viral DNA synthesis. Virology 2003, 311: 202-212.
26. Frankel FA, Marchand B, Turner D, Gotte M, Wainberg MA: Impaired rescue of chain-terminated DNA synthesis associated with the L74V mutation in human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 2005, 49: 2657-2664.
27. Abram ME, Parniak MA: Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain. J Virol 2005, 79: 11952-11961.